GlaxoSmithKline PLC Director/PDMR Shareholding (4082Q)
18 Febrero 2019 - 11:13AM
UK Regulatory
TIDMGSK
RNS Number : 4082Q
GlaxoSmithKline PLC
18 February 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
===================================================================================
a) Name Mr N Hirons
=== =============================== ==================================================
b) Position/status SVP, Global Ethics and Compliance
=== =============================== ==================================================
c) Initial notification/ Initial Notification
amendment
=== =============================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GlaxoSmithKline plc
=== =============================== ==================================================
b) LEI 5493000HZTVUYLO1D793
=== =============================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
=== =============================== ==================================================
b) Nature of the The exercise of nil-cost options over
transaction Ordinary Shares granted on 11 February
2016 under the Company's 2009 Deferred
Annual Bonus Plan - Deferred Bonus and
Matching Awards.
=== =============================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
=== =============================== ================ ============================
GBP0.0000 15,914 (Deferred)
=== =============================== ================ ============================
GBP0.0000 9,392 (Matching)
================ ============================
d) Aggregated information
===
Aggregated volume 25,306
Price GBP0.0000
=== =============================== ==================================================
e) Date of the transaction 2019-02-15
=== =============================== ==================================================
f) Place of the transaction n/a
=============================== ==================================================
1. Details of PDMR/person closely associated with them
('PCA')
====================================================================================
a) Name Mr N Hirons
=== ================================ ==================================================
b) Position/status SVP, Global Ethics and Compliance
=== ================================ ==================================================
c) Initial notification/ Initial Notification
amendment
=== ================================ ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ====================================================================================
a) Name GlaxoSmithKline plc
=== ================================ ==================================================
b) LEI 5493000HZTVUYLO1D793
=== ================================ ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ====================================================================================
a) Description of the Ordinary shares of 25 pence each ('Ordinary
financial instrument Shares')
ISIN: GB0009252882
=== ================================ ==================================================
b) Nature of the transaction The sale of Ordinary Shares to meet
tax liabilities on nil-cost options
over Ordinary Shares exercised on 15
February 2019 under the Company's Deferred
Annual Bonus Plan - Deferred Bonus and
Matching Awards.
=== ================================ ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
=== ================================ ================== ==========================
GBP15.9006 7,500 (Deferred)
=== ================================ ================== ==========================
GBP15.9006 4,425 (Matching)
================== ==========================
d) Aggregated information
===
Aggregated volume 11,925
Price GBP15.9006
=== ================================ ==================================================
e) Date of the transaction 2019-02-15
=== ================================ ==================================================
f) Place of the transaction London Stock Exchange (XLON)
================================ ==================================================
1. Details of PDMR/person closely associated with them
('PCA')
===================================================================================
a) Name Mr D Redfern
=== =============================== ==================================================
b) Position/status Chief Strategy Officer
=== =============================== ==================================================
c) Initial notification/ Initial Notification
amendment
=== =============================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GlaxoSmithKline plc
=== =============================== ==================================================
b) LEI 5493000HZTVUYLO1D793
=== =============================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
=== =============================== ==================================================
b) Nature of the The exercise of nil-cost options over
transaction Ordinary Shares granted on 11 February
2016 under the Company's 2009 Deferred
Annual Bonus Plan - Deferred Bonus and
Matching Awards.
=== =============================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
=== =============================== ================ ============================
GBP0.0000 20,254 (Deferred)
=== =============================== ================ ============================
GBP0.0000 11,952 (Matching)
================ ============================
d) Aggregated information
===
Aggregated volume 32,206
Price GBP0.0000
=== =============================== ==================================================
e) Date of the transaction 2019-02-15
=== =============================== ==================================================
f) Place of the transaction n/a
=============================== ==================================================
1. Details of PDMR/person closely associated with them
('PCA')
====================================================================================
a) Name Mr D Redfern
=== ================================ ==================================================
b) Position/status Chief Strategy Officer
=== ================================ ==================================================
c) Initial notification/ Initial Notification
amendment
=== ================================ ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ====================================================================================
a) Name GlaxoSmithKline plc
=== ================================ ==================================================
b) LEI 5493000HZTVUYLO1D793
=== ================================ ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ====================================================================================
a) Description of the Ordinary shares of 25 pence each ('Ordinary
financial instrument Shares')
ISIN: GB0009252882
=== ================================ ==================================================
b) Nature of the transaction The sale of Ordinary Shares to meet
tax liabilities on nil-cost options
over Ordinary Shares exercised on 15
February 2019 under the Company's Deferred
Annual Bonus Plan - Deferred Bonus and
Matching Awards.
=== ================================ ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
=== ================================ ================== ==========================
GBP15.878 9,545 (Deferred)
=== ================================ ================== ==========================
GBP15.878 5,631 (Matching)
================== ==========================
d) Aggregated information
===
Aggregated volume 15,176
Price GBP15.878
=== ================================ ==================================================
e) Date of the transaction 2019-02-15
=== ================================ ==================================================
f) Place of the transaction London Stock Exchange (XLON)
================================ ==================================================
1. Details of PDMR/person closely associated with them
('PCA')
===================================================================================
a) Name Ms C Thomas
=== =============================== ==================================================
b) Position/status SVP, Human Resources
=== =============================== ==================================================
c) Initial notification/ Initial Notification
amendment
=== =============================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GlaxoSmithKline plc
=== =============================== ==================================================
b) LEI 5493000HZTVUYLO1D793
=== =============================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
=== =============================== ==================================================
b) Nature of the The exercise of nil-cost options over
transaction Ordinary Shares granted on 11 February
2016 under the Company's 2009 Deferred
Annual Bonus Plan - Deferred Bonus and
Matching Awards.
=== =============================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
=== =============================== ================ ============================
GBP0.0000 29,636 (Deferred)
=== =============================== ================ ============================
GBP0.0000 17,488 (Matching)
================ ============================
d) Aggregated information
===
Aggregated volume 47,124
Price GBP0.0000
=== =============================== ==================================================
e) Date of the transaction 2019-02-15
=== =============================== ==================================================
f) Place of the transaction n/a
=============================== ==================================================
1. Details of PDMR/person closely associated with them
('PCA')
===================================================================================
a) Name Ms C Thomas
=== =============================== ==================================================
b) Position/status SVP, Human Resources
=== =============================== ==================================================
c) Initial notification/ Initial Notification
amendment
=== =============================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GlaxoSmithKline plc
=== =============================== ==================================================
b) LEI 5493000HZTVUYLO1D793
=== =============================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial instrument Shares')
ISIN: GB0009252882
=== =============================== ==================================================
b) Nature of the transaction The sale of Ordinary Shares to meet tax
liabilities on nil-cost options over
Ordinary Shares exercised on 15 February
2019 under the Company's Deferred Annual
Bonus Plan - Deferred Bonus and Matching
Awards.
=== =============================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
=== =============================== ================= ===========================
GBP15.8753 13,951 (Deferred)
=== =============================== ================= ===========================
GBP15.8753 8,232 (Matching)
================= ===========================
d) Aggregated information
===
Aggregated volume 22,183
Price GBP15.8753
=== =============================== ==================================================
e) Date of the transaction 2019-02-15
=== =============================== ==================================================
f) Place of the transaction London Stock Exchange (XLON)
=============================== ==================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHDVLFFKLFFBBF
(END) Dow Jones Newswires
February 18, 2019 12:13 ET (17:13 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De May 2023 a May 2024
